Showing results (11-20 of 18) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Alzheimer'S Research & Therapy|February 28, 2023
Masitinib for mild-to-moderate Alzheimer's disease: results from a randomized, placebo-controlled, phase 3, clinical trialBruno Dubois, Jesús López-Arrieta, Stanley Lipschitz, et al.Therapeutic Advances in Neurological Disorders|August 30, 2021
Long-term survival analysis of masitinib in amyotrophic lateral sclerosisJesus S Mora, Walter G Bradley, Delia Chaverri, et al.Arthritis Research & Therapy|June 25, 2009
Masitinib in the treatment of active rheumatoid arthritis: results of a multicentre, open-label, dose-ranging, phase 2a studyJacques Tebib, Xavier Mariette, Pierre Bourgeois, et al.Journal of Asthma and Allergy|June 14, 2022
Efficacy and Safety of Masitinib in Corticosteroid-Dependent Severe Asthma: A Randomized Placebo-Controlled TrialLavinia Davidescu, Grigoriy Ursol, Oleksii Korzh, et al.American Journal of Hematology|November 26, 2010
Masitinib for the treatment of systemic and cutaneous mastocytosis with handicap: a phase 2a studyCarle Paul, Beatrix Sans, Felipe Suarez, et al.Plos One|October 1, 2009
Masitinib (AB1010), a potent and selective tyrosine kinase inhibitor targeting KITPatrice Dubreuil, Sébastien Letard, Marco Ciufolini, et al.European Journal of Haematology|February 14, 2012
Mast cell leukemia: identification of a new c-Kit mutation, dup(501-502), and response to masitinib, a c-Kit tyrosine kinase inhibitorSophie Georgin-Lavialle, Ludovic Lhermitte, Felipe Suarez, et al.Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|July 9, 2019
Masitinib as an add-on therapy to riluzole in patients with amyotrophic lateral sclerosis: a randomized clinical trialJesus S Mora, Angela Genge, Adriano Chio, et al.Pageof 2